Connecting personalised medicine research in Canada with Europe
Connecting personalised medicine research in Canada with Europe
Cancer Core Europe
Roche joining forces to forward precision oncology
Effective implementation of personalised medicine guidelines
The significance of CEACAM 5 in metastases of triple negative breast cancer
The REACT trial: Celecoxib vs placebo for primary breast cancer
Rationale and recruitment in the PARTNER trial
The role of axiliary node dissection in modern breast cancer surgery
ER positive breast cancer: Screening for clinical variables to predict late distance disease recurrence
Predicting late breast cancer recurrence with screening assays
The SOFT trial: Comparing adjuvant tamoxifen with ovarian function suppression via exemestane to tamoxifen alone
How can scalp-cooling reduce chemotherapy induced hair loss?